US Patent 10053511 Anti-claudin antibodies and methods of use
All edits
Edits on 31 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+186 characters)
Article
Patent abstract
Provided herein are anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
Edits on 3 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
100535110
Date of Patent
August 21, 2018
0Patent Application Number
150349920
Date Filed
November 5, 2014
0Patent Citations Received
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
100535110
Date of Patent
August 21, 2018
0Patent Application Number
150349920
Date Filed
November 5, 2014
0Patent Citations Received
Patent Primary Examiner
Edits on 16 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10053511 Anti-claudin antibodies and methods of use
Infobox
Is a
Patent jurisdiction
Patent number
10053511
Date of patent
August 21, 2018
Patent application number
15034992
Date Filed
November 5, 2014
Patent primary examiner
Find more entities like US Patent 10053511 Anti-claudin antibodies and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.